Effects of Breathing Exercises in Women With Chronic Pelvic Pain

December 17, 2024 updated by: Saglik Bilimleri Universitesi

Investigation of the Clinical Effects of Breathing Exercises Combined With Pelvic Floor Exercises in Women With Chronic Pelvic Pain

The primary cause of the complex interaction of chronic pelvic pain originates from the visceral organs in the pelvic cavity, and it has been observed that musculoskeletal dysfunctions (such as increased muscle activity in the pelvic floor muscles) are often accompanied by visceral painful stimuli in the pelvic region as a result of shared innervation and visceral-somatic convergence.

This study aims to investigate the effect of breathing exercises combined with pelvic floor exercises on pain, pelvic floor muscle activity, psychological factors, and quality of life in women with chronic pelvic pain.

Study Overview

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • İstanbul Sağlık Bilimleri University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Be diagnosed with chronic pelvic pain (CPA)
  • Having pelvic pain for at least 6 months
  • 18-45 years old
  • Having high resting activity of the pelvic floor (>2 microvolts based on superficial EMG (sEMG) readings)

Exclusion Criteria:

  • Having a history of pelvic cancer and/or surgery
  • Receiving radiotherapy and/or chemotherapy
  • Having a neurological and/or psychiatric pathology
  • Have a urinary tract infection
  • Menopause
  • Presence of current pregnancy status
  • History of miscarriage and ectopic pregnancy
  • Presence of prolapse
  • Being >30 kg/cm2 according to body mass index (BMI)
  • Have received treatment for the pelvic area including manual therapy and electrotherapy in the last 6 months
  • Having had botulinum toxin injections in the pelvic region in the last 6 months
  • Having a communication problem

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Breathing Exercise Group
Combined breathing and pelvic floor exercises
Diaphragmatic breathing exercises with a physiotherapist for 8 weeks, two days a week
Pelvic floor exercises with a physiotherapist for 8 weeks, two days a week
Active Comparator: Control Group
Pelvic floor exercises
Pelvic floor exercises with a physiotherapist for 8 weeks, two days a week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline Pelvic Floor Muscle Activity (PFMA) at 8 weeks
Time Frame: at the baseline and end of the 8 weeks (16 sessions)
PFMA measurement will be performed with the sEMG NeuroTrac MyoPlus Pro (Verity Medical Ltd, UK) device integrated with computer software for digital analysis and report generation.
at the baseline and end of the 8 weeks (16 sessions)
Change from Baseline Visual Analogue Scale (VAS) at 8 weeks
Time Frame: at the baseline and end of the 8 weeks (16 sessions)
Pain severity will be evaluated with the VAS.
at the baseline and end of the 8 weeks (16 sessions)
Change from Baseline McGill Pain Scale- Short Form at 8 weeks
Time Frame: at the baseline and end of the 8 weeks (16 sessions)
The scale consists of 3 parts. In the first part of the scale, a total of 3 pain scores are obtained: sensory pain score, perceptual pain score and total pain score. In the second part, there were five word groups ranging from "mild pain" to "unbearable pain" to determine the severity of the patient's pain. In the third part, the current pain intensity of the patient was evaluated using a visual comparison scale.
at the baseline and end of the 8 weeks (16 sessions)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Global Pelvic Floor Disorder Questionnaire
Time Frame: at the baseline and end of the 8 weeks
Global pelvic floor disorders will be evaluated at baseline and after 8 weeks
at the baseline and end of the 8 weeks
Corbin Postural Rating Scale
Time Frame: at the baseline and end of the 8 weeks
Measuring of posture changes
at the baseline and end of the 8 weeks
Pelvic Pain Impact Questionnaire
Time Frame: at the baseline and end of the 8 weeks
Clinical evaluation of pelvic pain effect
at the baseline and end of the 8 weeks
Short Form-36
Time Frame: at the baseline and end of the 8 weeks
Evaluation of quality of life
at the baseline and end of the 8 weeks
Depression, Anxiety and Stress Scale
Time Frame: at the baseline and end of the 8 weeks
Evaluation of moods (depression, anxiety and stress)
at the baseline and end of the 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2023

Primary Completion (Actual)

April 1, 2024

Study Completion (Actual)

June 1, 2024

Study Registration Dates

First Submitted

May 2, 2023

First Submitted That Met QC Criteria

May 16, 2023

First Posted (Actual)

May 25, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 17, 2024

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pelvic Pain Syndrome

Clinical Trials on Breathing Exercises

Subscribe